Opening book details…
About this Medicine article
Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma by Rubinstein, Paul G.; Moore, Page C.; Rudek, Michelle A.; Henry, David H.; Ramos, Juan C.; Ratner, Lee; Reid, Erin; Sharon, Elad; Noy, Ariela is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Rubinstein, Paul G.; Moore, Page C.; Rudek, Michelle A.; Henry, David H.; Ramos, Juan C.; Ratner, Lee; Reid, Erin; Sharon, Elad; Noy, Ariela
- Publisher
- Lippincott Williams and Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 0269-9370)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)